Literature DB >> 1777351

Tc-99m labeled tissue-type plasminogen activator: preparation, stability and preliminary imaging of thrombus-bearing rats.

K Itoh1, E Tsukamoto, T Nishibe, S Sakurama, M Ieko, T Tanabe, M Furudate.   

Abstract

Tissue-type plasminogen activator (t-PA) is a thrombolytic agent that directly binds to fibrin formed in clots. In terms of radiolabeling and nuclear imaging, t-PA has several advantages in Tc-99m labeling: it is stable in acidic solution at pH 3, which is suitable for labeling Tc-99m by a method of stannous reduction and blood disappearance after administration is rapid, which is desirable for imaging targets using short-lived radionuclides. Recombinant t-PA was labeled with Tc-99m by a method of stannous reduction without significant degradation of biochemical activity, over 95% of which was retained after the labeling procedure. Labeling efficiency in paper chromatography was over 98%. The moiety of hydrolyzed Tc-99m that was not eluted through the Sephadex column was estimated to be less than 10%. Tc-99m labeled t-PA, however, appeared to become unstable when diluted with normal saline. Nevertheless, in in vitro fibrin binding, Tc-99m labeled t-PA showed high affinity with fibrin: 80% of 100 ng/ml of Tc-99m t-PA bound to 10(-5) mol of the fibrinogen. Preliminary animal studies also showed a concentration of Tc-99m labeled t-PA at fresh thrombi formed in the inferior vena cava. Tc-99m labeled t-PA appears to have potential for thrombus imaging and the preparation of an instant kit.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1777351     DOI: 10.1007/bf03164615

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  20 in total

Review 1.  Venous thromboembolism.

Authors:  K M Moser
Journal:  Am Rev Respir Dis       Date:  1990-01

2.  Labeling of human clots in vitro with an active-site mutant of t-PA.

Authors:  E T Fry; D L Mack; J C Monge; J J Billadello; B E Sobel
Journal:  J Nucl Med       Date:  1990-02       Impact factor: 10.057

3.  Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial.

Authors:  D O Williams; J Borer; E Braunwald; J H Chesebro; L S Cohen; J Dalen; H T Dodge; C K Francis; G Knatterud; P Ludbrook
Journal:  Circulation       Date:  1986-02       Impact factor: 29.690

4.  Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.

Authors:  M Hoylaerts; D C Rijken; H R Lijnen; D Collen
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

5.  Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus.

Authors:  O Matsuo; D C Rijken; D Collen
Journal:  Nature       Date:  1981-06-18       Impact factor: 49.962

6.  A sensitive assay for tissue plasminogen activator.

Authors:  M Rånby; B Norrman; P Wallén
Journal:  Thromb Res       Date:  1982-09-15       Impact factor: 3.944

7.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

Authors: 
Journal:  N Engl J Med       Date:  1985-04-04       Impact factor: 91.245

8.  Inactivation of tissue plasminogen activator in plasma. Demonstration of a complex with a new rapid inhibitor.

Authors:  B Wiman; J Chmielewska; M Rånby
Journal:  J Biol Chem       Date:  1984-03-25       Impact factor: 5.157

9.  Radioimmunoimaging of experimental thrombi in dogs using technetium-99m-labeled monoclonal antibody fragments reactive with human platelets.

Authors:  P Som; Z H Oster; P O Zamora; K Yamamoto; D F Sacker; A B Brill; K D Newell; B A Rhodes
Journal:  J Nucl Med       Date:  1986-08       Impact factor: 10.057

10.  Binding of 131I-labeled tissue-type plasminogen activator on de-endothelialized lesions in rabbits.

Authors:  A Uehara; Y Isaka; H Etani; K Kimura; S Yoneda; T Kamada; T Kozuka; M Nobuhara
Journal:  Nuklearmedizin       Date:  1987-10       Impact factor: 1.379

View more
  2 in total

1.  In vivo distribution of Tc-99m labeled recombinant tissue-type plasminogen activator in control and thrombus-bearing rats.

Authors:  E Tsukamoto
Journal:  Ann Nucl Med       Date:  1992-08       Impact factor: 2.668

2.  In vivo kinetics of 99mTc labeled recombinant tissue plasminogen activator in rabbits.

Authors:  K Itoh; M Ieko; E Hiraguchi; H Kitayama; E Tsukamoto
Journal:  Ann Nucl Med       Date:  1994-08       Impact factor: 2.668

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.